{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T05:06:02Z","timestamp":1780031162301,"version":"3.53.1"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    Dedifferentiated liposarcoma (DDLPS) is a high-grade soft tissue sarcoma predominantly arising in the retroperitoneum, characterized by an insidious clinical course. This study reports a 63-year-old female patient who presented with abdominal distension and decreased appetite, without other systemic complaints. Malignant tumor cells were identified in both ascitic smears and cell blocks. Combined with immunohistochemical (IHC) staining, the findings were consistent with sarcoma cells. Fluorescence\n                    <jats:italic>in situ<\/jats:italic>\n                    hybridization (FISH) analysis of the tissue biopsy revealed clustered amplification of mouse double minute 2 homolog (MDM2) gene. Based on the combined results of IHC and FISH testing, the final pathological diagnosis of the tissue biopsy was DDLPS. To the best of existing knowledge, this is one of the few reported cases of DDLPS initially manifesting with malignant cells detected in peritoneal fluid. This case highlights the diagnostic challenge of rare sarcomas presenting with serosal effusions and emphasizes the importance of integrating cytopathological, radiological, and molecular testing for accurate diagnosis and optimal management. Preventing misdiagnosis of this tumor as other histological subtypes is of great clinical significance, while IHC features and FISH can provide important clues for its accurate diagnosis.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2026.1862667","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:56:03Z","timestamp":1780030563000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Dedifferentiated liposarcoma presenting with ascites as the initial clinical manifestation: a case report and literature review"],"prefix":"10.3389","volume":"13","author":[{"given":"JingJun","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Changyi People\u2019s Hospital","place":["Changyi, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LiQian","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Weifang People\u2019s Hospital (First Affiliated Hospital of Shandong Second Medical University)","place":["Weifang, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MaoTao","family":"He","sequence":"additional","affiliation":[{"name":"Department of Pathology, Weifang People\u2019s Hospital (First Affiliated Hospital of Shandong Second Medical University)","place":["Weifang, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MaiQing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Weifang People\u2019s Hospital (First Affiliated Hospital of Shandong Second Medical University)","place":["Weifang, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1200\/jco.2017.74.9598","article-title":"Clinical and molecular Spectrum of Liposarcoma","volume":"36","author":"Lee","year":"2018","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1148\/rg.255055106","article-title":"From the archives of the Afip: imaging of musculoskeletal liposarcoma with radiologic-pathologic correlation","volume":"25","author":"Murphey","year":"2005","journal-title":"Radiographics"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.3390\/jcm10153230","article-title":"Biology and Management of Dedifferentiated Liposarcoma: state of the art and perspectives","volume":"10","author":"Nishio","year":"2021","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/curroncol32080473","article-title":"Construction and verification of a predictive nomogram for overall survival in patients with large retroperitoneal liposarcoma: a population-based cohort study","volume":"32","author":"Deng","year":"2025","journal-title":"Curr Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1053\/j.semdp.2019.02.006","article-title":"Well-differentiated Liposarcoma and dedifferentiated Liposarcoma: an updated review","volume":"36","author":"Thway","year":"2019","journal-title":"Semin Diagn Pathol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1148\/rg.2017160201","article-title":"Soft-tissue sarcomas of the abdomen and pelvis: radiologic-pathologic features, part 2-uncommon sarcomas","volume":"37","author":"Levy","year":"2017","journal-title":"Radiographics"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1159\/000540368","article-title":"Intraperitoneal dedifferentiated Liposarcoma: unveiling a rare diagnosis in peritoneal fluid cytology - a case report with literature review","volume":"68","author":"Prabhu","year":"2024","journal-title":"Acta Cytol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11864-020-0705-7","article-title":"Dedifferentiated Liposarcoma: systemic therapy options","volume":"21","author":"Gahvari","year":"2020","journal-title":"Curr Treat Options in Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/cncy.22431","article-title":"Bone and soft tissue sarcomas in cerebrospinal fluid and effusion: a 20-year review at our institution","volume":"129","author":"Sharma","year":"2021","journal-title":"Cancer Cytopathol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1097\/01.pas.0000170343.09562.39","article-title":"Mdm2 and Cdk4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data","volume":"29","author":"Binh","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"9571","DOI":"10.3390\/ijms24119571","article-title":"Treatment of De-differentiated Liposarcoma in the era of immunotherapy","volume":"24","author":"Zhou","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1002\/bjs.10305","article-title":"Preoperative radiotherapy in the management of retroperitoneal liposarcoma","volume":"103","author":"Ecker","year":"2016","journal-title":"Br J Surg"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"6626","DOI":"10.1158\/0008-5472.Can-07-0584","article-title":"Gene expression profiling of Liposarcoma identifies distinct biological types\/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated Liposarcoma","volume":"67","author":"Singer","year":"2007","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1177\/10668969231206344","article-title":"Liposarcoma involving serous fluid cavities-a case series illustrating clinical implications and the diagnostic role of exfoliative cytology","volume":"32","author":"Ng","year":"2024","journal-title":"Int J Surg Pathol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/s0720-048x(00)00168-6","article-title":"Malignant pleural disease","volume":"34","author":"Bonomo","year":"2000","journal-title":"Eur J Radiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"102846","DOI":"10.1016\/j.ctrv.2024.102846","article-title":"Diagnosis and Management of Dedifferentiated Liposarcoma: a multidisciplinary position statement","volume":"131","author":"Haddox","year":"2024","journal-title":"Cancer Treat Rev"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/cncy.22398","article-title":"Diagnostic mesothelioma biomarkers in effusion cytology","volume":"129","author":"Eccher","year":"2021","journal-title":"Cancer Cytopathol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4103\/cytojournal.cytojournal_20_19","article-title":"Cellblockistry: chemistry and art of cell-block making - a detailed review of various historical options with recent advances","volume":"16","author":"Shidham","year":"2019","journal-title":"Cytojournal"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1515\/cclm-2023-1112","article-title":"Differential diagnosis of ascites: etiologies, ascitic fluid analysis, diagnostic algorithm","volume":"62","author":"Du","year":"2024","journal-title":"Clin Chem Lab Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.soc.2021.02.004","article-title":"A palliative approach to management of peritoneal Carcinomatosis and malignant ascites","volume":"30","author":"Bleicher","year":"2021","journal-title":"Surg Oncol Clin N Am"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1006959","DOI":"10.3389\/fonc.2022.1006959","article-title":"Targeting the Mdm2-P53 pathway in dedifferentiated Liposarcoma","volume":"12","author":"Traweek","year":"2022","journal-title":"Front Oncol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3892\/ol.2025.15015","article-title":"Ferroptosis as a therapeutic vulnerability in Mdm2 inhibition in dedifferentiated Liposarcoma","volume":"29","author":"Yen","year":"2025","journal-title":"Oncol Lett"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3747\/co.27.5407","article-title":"Immunotherapy in soft-tissue sarcoma","volume":"27","author":"Ayodele","year":"2020","journal-title":"Current Oncol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/s1470-2045(17)30624-1","article-title":"Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (Sarc028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial","volume":"18","author":"Tawbi","year":"2017","journal-title":"Lancet Oncol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1862667\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:56:09Z","timestamp":1780030569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1862667\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":24,"alternative-id":["10.3389\/fmed.2026.1862667"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1862667","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"article-number":"1862667"}}